M-tron Industries Files 424B2 Prospectus
Ticker: MPTI · Form: 424B2 · Filed: Mar 30, 2026 · CIK: 0001902314
Sentiment: neutral
Topics: prospectus, securities-offering, filing
Related Tickers: MTRN
TL;DR
MTRN filed a prospectus for a securities offering. Details TBD.
AI Summary
M-tron Industries, Inc. filed a 424B2 prospectus on March 30, 2026, related to a previous registration statement. The filing details the terms of a securities offering, but specific dollar amounts, dates of sale, and the underwriter are not provided in this excerpt.
Why It Matters
This filing indicates M-tron Industries is actively pursuing a securities offering, which could impact its capital structure and future operations.
Risk Assessment
Risk Level: low — The filing is a standard prospectus supplement and does not contain new material adverse information.
Key Numbers
- 516956 — Form 424B2 Size (Indicates the size of the prospectus document filed.)
- 705218 — Complete Submission Text File Size (Size of the full submission text file.)
Key Players & Entities
- M-tron Industries, Inc. (company) — Filer of the prospectus
- 0001902314 (company) — CIK number for M-tron Industries, Inc.
- 2026-03-30 (date) — Filing date of the 424B2 prospectus
- 333-284635 (dollar_amount) — File number associated with the registration statement
FAQ
What is the purpose of the 424B2 filing?
The 424B2 filing is a prospectus supplement used to provide details about a securities offering that was previously registered.
When was this prospectus filed?
The prospectus was filed on March 30, 2026.
What is the CIK number for M-tron Industries, Inc.?
The CIK number for M-tron Industries, Inc. is 0001902314.
What is the SIC code for M-tron Industries, Inc.?
The SIC code for M-tron Industries, Inc. is 3679, which corresponds to Electronic Components, NEC.
Does this filing specify the exact number of shares or the price of the offering?
This excerpt of the filing does not specify the exact number of shares or the price of the offering; it serves as a supplement to a previously filed registration statement.
Filing Stats: 4,486 words · 18 min read · ~15 pages · Grade level 14.3 · Accepted 2026-03-30 09:03:11
Key Financial Figures
- $0.01 — chase shares of common stock, par value $0.01 per share (the "Common Stock"), of M-tr
- $69.03 — e Common Stock on the NYSE American was $69.03. The Company has declared a distributi
- $59 — Stock at a subscription price equal to, $59.00, which is an approximately twelve pe
- $42.1 m — Rights is expected to be approximately $42.1 million, after deducting our estimated ex
Filing Documents
- mpti20260329c_424b2.htm (424B2) — 505KB
- ex_938753.htm (EX-FILING FEES) — 29KB
- logo-mtronnotagsmall.jpg (GRAPHIC) — 11KB
- mtronlogosmall.jpg (GRAPHIC) — 7KB
- 0001437749-26-010183.txt ( ) — 689KB
- ex_938753_htm.xml (XML) — 7KB
Use of Proceeds
Use of Proceeds S-11 Plan of Distribution S-12
Description of Capital Stock
Description of Capital Stock S-13 Description of Rights S-16 U.S. Federal Income Tax Consequences S-21 Legal Matters S-23 Experts S-24 Where You Can Find More Information S-25 Incorporation of Certain Documents by Reference S-26 Prospectus Page About this Prospectus 1 Cautionary Note Regarding Forward-Looking Statements 2 The Company 3
Description of Securities
Description of Securities 7
Description of Capital Stock
Description of Capital Stock 8 Description of Warrants 11 Description of Depositary Shares 12 Description of Subscription Rights 14 Description of Units 15 Book Entry Procedures and Settlement 16 Plan of Distribution 17 Legal Matters 19 Experts 20 Where You Can Find More Information 21 Incorporation of Certain Documents by Reference 22 Table of Contents ABOUT THIS PROSPECTUS SUPPLEMENT This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of this offering and the securities offered hereby, and also adds to and updates information contained in the accompanying base prospectus and the documents incorporated by reference into this prospectus supplement and the base prospectus. The second part, the base prospectus, gives more general information and disclosure. When we refer only to the prospectus, we are referring to both parts combined, and when we refer to the accompanying prospectus, we are referring to the base prospectus. If there is any inconsistency between information contained in or incorporated by reference into the base prospectus and information contained in or incorporated by reference into this prospectus supplement, you should rely only on the information contained in or incorporated by reference into this prospectus supplement. This prospectus supplement, the accompanying prospectus and the documents incorporated into each by reference include important information about us, the shares being offered and other information you should know before investing. You should read this prospectus supplement and the accompanying prospectus together with the additional information described in this prospectus supplement under the headings " Where You Can Find More Information " and " Incorporation of Certain Documents by Reference " before investing in the Rights or our Common Stock. You should rely only on the information contained in or incorporated by refer
Use of Proceeds
Use of Proceeds The purpose of this Rights Offering is to raise capital to support the Company's efforts to continue to increase earnings and shareholder return. This capital may be used for potential acquisitions, strategic investments, investment in a strategic RF fund, and/or general corporate purposes, which may include working capital, capital expenditures and repayment or refinancing of outstanding indebtedness (if any). Assuming that all Rights are exercised, the net proceeds from the exercise of the Rights is expected to be approximately $42.1 million, after deducting our estimated expenses related to the Rights Offering. Board Recommendation The Board will make no recommendation as to whether or not a stockholder should exercise any Rights or otherwise participate in the Rights Offering. No Revocation Once a Rights holder submits the form of subscription rights certificate to exercise any Rights, such holder may not revoke or change their exercise or request a refund of monies paid. All exercises of Rights are irrevocable. Governing Law The Rights will be governed by the laws of the State of Delaware. Subscription Agent Computershare Trust Company, N.A. Information Agent Georgeson LLC
Risk Factors
Risk Factors An investment in the Rights and the shares of Common Stock issuable upon exercise of the Rights involves significant financial risk. You should carefully read the section entitled " Risk Factors " on page S-10 of this prospectus supplement, as well as in our reports incorporated by reference herein, before you make a decision as to the exercise of your Rights to determine whether an investment in our securities is appropriate for you. U.S. Federal Income Tax Consequences You should carefully read the section entitled " Certain U.S. Federal Income Tax Consequences " on page S-21 of this prospectus supplement, and consult your tax advisor on tax treatment of the Rights and exercise thereof. S-6 Table of Contents QUESTIONS AND ANSWERS ABOUT THE RIGHTS OFFERING The following is a brief summary of the terms of the Rights Offering. Please see " Description of Rights " for a more detailed description of the matters described below. What is a rights offering? A rights offering is a distribution of subscription rights on a pro rata basis to stockholders of a company. We will distribute to holders of our Common Stock as of the Record Date, one (1) transferable subscription right for each share of Common Stock held as of the Record Date. What are the record and distribution dates for the Rights Offering? Each holder of record of shares of our Common Stock as of 5:00 p.m., Eastern Time, on March 27, 2026 will be entitled to receive Rights on the Rights Distribution Date, which will be 5:00 p.m., Eastern Time, on March 30, 2026. Are there other key dates relating to the Rights Offering? Yes. Below is a list of the key dates for the rights offering of which you should be aware. Date Event March 27, 2026 Record Date for the Rights Offering March 30, 2026 Rights Distribution Date March 31, 2026 Rights Offering commencement and trading date; Rights expected to begin trading on the NYSE American under the symbol "MPTI RT" April 15, 2026 E